Stocks and Investing Stocks and Investing
Fri, February 16, 2024

John Sourbeer Maintained (WST) at Hold with Decreased Target to $375 on, Feb 16th, 2024


Published on 2024-10-28 09:01:22 - WOPRAI, John Sourbeer
  Print publication without navigation


John Sourbeer of UBS, Maintained "West Pharmaceutical Services, Inc." (WST) at Hold with Decreased Target from $400 to $375 on, Feb 16th, 2024.

John has made no other calls on WST in the last 4 months.



There are 3 other peers that have a rating on WST. Out of the 3 peers that are also analyzing WST, 0 agree with John's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with John


  • Paul Knight of "Keybanc" Maintained at Buy with Increased Target to $470 on, Tuesday, February 13th, 2024
  • David Windley of "Jefferies" Upgraded from Hold to Strong Buy and Increased Target to $536 on, Wednesday, February 7th, 2024
  • Jacob Johnson of "Stephens & Co." Maintained at Buy with Decreased Target to $390 on, Friday, October 27th, 2023
Contributing Sources